Testosterone Recovery and Associated Impact on PatientReported Health -Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial Meeting Abstract
| Authors: | Moningi, S.; Nguyen, P. L.; Rathkopf, D.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; Bubley, G.; Yu, J. B.; An, Y.; Wong, A. G.; Feng, F. Y.; McKay, R. R.; Rose, B. S.; Shin, K. Y.; Taplin, M. E. A.; Kollmeier, M. A.; Hoffman, K. E. |
| Abstract Title: | Testosterone Recovery and Associated Impact on PatientReported Health -Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial |
| Meeting Title: | 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2024) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 120 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2024 Sep 29-Oct 2 |
| Meeting Location: | Washington, DC |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | e563 |
| End Page: | e564 |
| Language: | English |
| ACCESSION: | WOS:001325892301567 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2024.07.1247 |
| Notes: | Meeting Abstract: 3243 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
